Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Bibliografske podrobnosti
Main Authors: Shah, V, Sherborne, AL, Johnson, DC, Ellis, S, Price, A, Chowdhury, F, Kendall, J, Jenner, MW, Drayson, MT, Owen, RG, Gregory, WM, Morgan, GJ, Davies, FE, Cook, G, Cairns, DA, Houlston, RS, Jackson, G, Kaiser, MF, NCRI Haematology Clinical Studies Group
Drugi avtorji: Schuh, A
Format: Journal article
Jezik:English
Izdano: Springer Nature 2020
Teme:
_version_ 1826293730036940800
author Shah, V
Sherborne, AL
Johnson, DC
Ellis, S
Price, A
Chowdhury, F
Kendall, J
Jenner, MW
Drayson, MT
Owen, RG
Gregory, WM
Morgan, GJ
Davies, FE
Cook, G
Cairns, DA
Houlston, RS
Jackson, G
Kaiser, MF
NCRI Haematology Clinical Studies Group
author2 Schuh, A
author_facet Schuh, A
Shah, V
Sherborne, AL
Johnson, DC
Ellis, S
Price, A
Chowdhury, F
Kendall, J
Jenner, MW
Drayson, MT
Owen, RG
Gregory, WM
Morgan, GJ
Davies, FE
Cook, G
Cairns, DA
Houlston, RS
Jackson, G
Kaiser, MF
NCRI Haematology Clinical Studies Group
author_sort Shah, V
collection OXFORD
description
first_indexed 2024-03-07T03:34:39Z
format Journal article
id oxford-uuid:bbe06aef-410f-4fc4-a4cb-cf8c8ecf0259
institution University of Oxford
language English
last_indexed 2024-03-07T03:34:39Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:bbe06aef-410f-4fc4-a4cb-cf8c8ecf02592022-03-27T05:20:22ZPredicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsJournal articlehttp://purl.org/coar/resource_type/c_1843uuid:bbe06aef-410f-4fc4-a4cb-cf8c8ecf0259Cancer geneticsCancer genomicsMyelomaEnglishSymplectic ElementsSpringer Nature2020Shah, VSherborne, ALJohnson, DCEllis, SPrice, AChowdhury, FKendall, JJenner, MWDrayson, MTOwen, RGGregory, WMMorgan, GJDavies, FECook, GCairns, DAHoulston, RSJackson, GKaiser, MFNCRI Haematology Clinical Studies GroupSchuh, AStanworth, SMead, A
spellingShingle Cancer genetics
Cancer genomics
Myeloma
Shah, V
Sherborne, AL
Johnson, DC
Ellis, S
Price, A
Chowdhury, F
Kendall, J
Jenner, MW
Drayson, MT
Owen, RG
Gregory, WM
Morgan, GJ
Davies, FE
Cook, G
Cairns, DA
Houlston, RS
Jackson, G
Kaiser, MF
NCRI Haematology Clinical Studies Group
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title_full Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title_fullStr Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title_full_unstemmed Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title_short Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
title_sort predicting ultrahigh risk multiple myeloma by molecular profiling an analysis of newly diagnosed transplant eligible myeloma xi trial patients
topic Cancer genetics
Cancer genomics
Myeloma
work_keys_str_mv AT shahv predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT sherborneal predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT johnsondc predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT elliss predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT pricea predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT chowdhuryf predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT kendallj predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT jennermw predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT draysonmt predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT owenrg predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT gregorywm predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT morgangj predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT daviesfe predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT cookg predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT cairnsda predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT houlstonrs predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT jacksong predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT kaisermf predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients
AT ncrihaematologyclinicalstudiesgroup predictingultrahighriskmultiplemyelomabymolecularprofilingananalysisofnewlydiagnosedtransplanteligiblemyelomaxitrialpatients